{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:14:33Z","timestamp":1787015673789,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":3080,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Blood Transfusion Center of the German Red Cross Baden-W\u00fcrttemberg-Hessen","award":["GRK-1172"],"award-info":[{"award-number":["GRK-1172"]}]},{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/jth.12572","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:44:39Z","timestamp":1396028679000},"page":"932-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oral gene therapy for hemophilia B using chitosan\u2010formulated FIX mutants"],"prefix":"10.1016","volume":"12","author":[{"given":"P.","family":"Quade\u2010Lyssy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Milanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Abriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"K\u00f6nigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sch\u00fcttrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12572_bb0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2012.01750.x","article-title":"Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life","volume":"88","author":"Khawaji","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1111\/jth.12572_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/73464","article-title":"Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector","volume":"24","author":"Kay","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/jth.12572_bb0020","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV\u2010mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV\u2010Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1111\/jth.12572_bb0030","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus\u2010associated virus vector\u2010mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12572_bb0035","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2012-05-432591","article-title":"Hyperfunctional coagulation factor IX improves the efficacy of gene therapy in hemophilic mice","volume":"120","author":"Cantore","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0040","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-06-440123","article-title":"The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy","volume":"120","author":"Finn","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1160\/TH13-02-0154","article-title":"Incorporation of the factor IX Padua mutation into FIX\u2010Triple improves clotting activity in vitro and in vivo","volume":"110","author":"Kao","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12572_bb0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood-2011-05-353672","article-title":"Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice","volume":"119","author":"Milanov","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0055","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2004-08-2990","article-title":"Factor IX variants improve gene therapy efficacy for hemophilia B","volume":"105","author":"Schuettrumpf","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","article-title":"Oral tolerance","volume":"241","author":"Weiner","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1111\/jth.12572_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/nano.2006.1.2.117","article-title":"Chitosan nanoparticles for oral drug and gene delivery","volume":"1","author":"Bowman","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1111\/jth.12572_bb0070","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1538-7836.2009.03560.x","article-title":"Factor IX mutants with enhanced catalytic activity","volume":"7","author":"Hartmann","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12572_bb0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","article-title":"Chitosan\u2010DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency","volume":"70","author":"Mao","year":"2001","journal-title":"J Control Release"},{"key":"10.1111\/jth.12572_bb0080","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X\u2010linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12572_bb0085","doi-asserted-by":"crossref","first-page":"25393","DOI":"10.1074\/jbc.M105432200","article-title":"Identification of functionally important residues of the epidermal growth factor\u20102 domain of factor IX by alanine\u2010scanning mutagenesis. Residues Asn(89)\u2010Gly(93) are critical for binding factor VIIIa","volume":"277","author":"Chang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12572_bb0090","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.93.20.11068","article-title":"Identification of the endothelial cell binding site for factor IX","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12572_bb0095","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2009.03545.x","article-title":"Abnormal hemostasis in a knock\u2010in mouse carrying a variant of factor IX with impaired binding to collagen type IV","volume":"7","author":"Gui","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12572_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3390217","article-title":"Regions 301\u2010303 and 333\u2010339 in the catalytic domain of blood coagulation factor IX are factor VIII\u2010interactive sites involved in stimulation of enzyme activity","volume":"339","author":"Kolkman","year":"1999","journal-title":"Biochem J"},{"key":"10.1111\/jth.12572_bb0105","doi-asserted-by":"crossref","first-page":"18477","DOI":"10.1074\/jbc.274.26.18477","article-title":"Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa","volume":"274","author":"Mathur","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12572_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2008.06.019","article-title":"Gene transfer to hemophilia A mice via oral delivery of FVIII\u2010chitosan nanoparticles","volume":"132","author":"Bowman","year":"2008","journal-title":"J Control Release"},{"key":"10.1111\/jth.12572_bb0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3748\/wjg.v10.i1.112","article-title":"Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan\u2010DNA nanoparticles","volume":"10","author":"Chen","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1111\/jth.12572_bb0120","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/S0264-410X(03)00228-7","article-title":"Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice","volume":"21","author":"Chew","year":"2003","journal-title":"Vaccine"},{"key":"10.1111\/jth.12572_bb0125","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1538-7836.2010.04116.x","article-title":"Repeated oral administration of chitosan\/DNA nanoparticles delivers functional FVIII with the absence of antibodies in hemophilia A mice","volume":"8","author":"Dhadwar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12572_bb0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/7385","article-title":"Oral gene delivery with chitosan\u2013DNA nanoparticles generates immunologic protection in a murine model of peanut allergy","volume":"5","author":"Roy","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/jth.12572_bb0135","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/hum.1997.8.12-1481","article-title":"Gut epithelial cells as targets for gene therapy of hemophilia","volume":"8","author":"Lozier","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1111\/jth.12572_bb0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2005-11-4668","article-title":"Immune deviation by mucosal antigen administration suppresses gene\u2010transfer\u2010induced inhibitor formation to factor IX","volume":"108","author":"Cao","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12572_bb0145","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1073\/pnas.0912181107","article-title":"Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice","volume":"107","author":"Verma","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.12572_bb0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"6","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/jth.12572_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/cmi.2009.6","article-title":"Induction of Th1\u2010type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice","volume":"6","author":"Li","year":"2009","journal-title":"Cell Mol Immunol"},{"key":"10.1111\/jth.12572_bb0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"10.1111\/jth.12572_bb0165","first-page":"013","article-title":"Engineered factor VII, factor IX and factor X variants for hemophilia gene therapy","volume":"S1","author":"Quade\u2010Lyssy","year":"2012","journal-title":"J Genet Syndr Gene Ther"},{"key":"10.1111\/jth.12572_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-6411(03)00155-3","article-title":"Chitosan\u2010DNA nanoparticles as non\u2010viral vectors in gene therapy: strategies to improve transfection efficacy","volume":"57","author":"Mansouri","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1111\/jth.12572_bb0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/138955709787847976","article-title":"Chitosan micro\u2010 and nanospheres: fabrication and applications for drug and DNA delivery","volume":"9","author":"Masotti","year":"2009","journal-title":"Mini Rev Med Chem"},{"key":"10.1111\/jth.12572_bb0180","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1248\/cpb.58.1423","article-title":"Chitosan nanoparticles: a promising system in novel drug delivery","volume":"58","author":"Nagpal","year":"2010","journal-title":"Chem Pharm Bull (Tokyo)"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12572","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12572","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12572\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:07:53Z","timestamp":1761534473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622039617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1538783622039617"],"URL":"https:\/\/doi.org\/10.1111\/jth.12572","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral gene therapy for hemophilia B using chitosan\u2010formulated FIX mutants","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}